4//SEC Filing
Migliarese Antonio 4
Accession 0001104659-24-001956
CIK 0001175680other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:04 PM ET
Size
30.3 KB
Accession
0001104659-24-001956
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Migliarese Antonio
Chief Financial Officer
Transactions
- Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−1,000,000→ 0 totalExercise: $1.32Exp: 2031-08-06→ Common Stock (1,000,000 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+100,000→ 100,000 totalExercise: $0.21From: 2024-01-03Exp: 2030-07-22→ Common Stock (100,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−50,000→ 0 totalExercise: $5.54Exp: 2031-02-17→ Common Stock (50,000 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+50,000→ 50,000 totalExercise: $0.21From: 2024-01-03Exp: 2030-01-16→ Common Stock (50,000 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+1,000,000→ 1,000,000 totalExercise: $0.21Exp: 2031-08-06→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−50,000→ 0 totalExercise: $1.03Exp: 2030-01-16→ Common Stock (50,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−100,000→ 0 totalExercise: $5.57Exp: 2030-07-22→ Common Stock (100,000 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+50,000→ 50,000 totalExercise: $0.21Exp: 2031-02-17→ Common Stock (50,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−50,000→ 0 totalExercise: $1.10Exp: 2030-02-21→ Common Stock (50,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2024-01-03−630,222→ 0 totalExercise: $0.58Exp: 2032-09-20→ Common Stock (630,222 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+50,000→ 50,000 totalExercise: $0.21From: 2024-01-03Exp: 2030-02-21→ Common Stock (50,000 underlying) - Award
Non-qualified stock option (right to buy)
2024-01-03+630,222→ 630,222 totalExercise: $0.21Exp: 2032-09-20→ Common Stock (630,222 underlying)
Footnotes (8)
- [F1]The option was fully vested and exercisable prior to January 3, 2024.
- [F2]The outstanding option was cancelled in exchange for a new option having a lower exercise price.
- [F3]Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022.
- [F4]Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022.
- [F5]25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
- [F6]33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024.
- [F7]666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024.
- [F8]301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026.
Documents
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001864040
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:04 PM ET
- Size
- 30.3 KB